Covid-19: Remdesivir output to be doubled to 7.4 mn doses by April-end

18 new sites get DCGI consent to make antiviral used for treating Covid-19

Sohini Das | Mumbai
Last Updated at April 19, 2021 06:10 IST

Remdesivir, coronavirus, covid-19, drugs, medicine, health

Daily supplies have already more than doubled. From around 70,000 doses per day hitting the market as on April 10, supplies have now touched 140,000-200,000 doses per day

India’s Remdesivir shortage may be shortlived as a stock of 7.4 million doses is likely to be available by the end of this month or the first week of May, claimed sources.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

MONTHLY

₹ 249

Select

ANNUAL

₹ 1799

Select

Best Offer

SMART ANNUAL

₹ 1499

₹ 1799

Opt for auto renewal and save Rs 300

Select

What you get on Business Standard Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Pick your 5 favourite companies, get a daily email with all news updates on them.
26 years of website archives.
Preferential invites to Business Standard events.